Labs / CDMO: development & manufacturing

ADC Therapeutics
New Providence, NJ, United States · adctherapeutics.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
ADC Therapeutics is a biopharmaceutical company focused on antibody-drug conjugates for cancer. It develops and commercializes ZYNLONTA® for adults with certain types of relapsed or refractory large B-cell lymphoma and works from locations in New Providence, New Jersey and Epalinges, Switzerland.
Their website has a general contact form; we send your quote request through it.
What they offer
Develop antibody-drug conjugate therapeutics
Develops ADC-based cancer therapies from its focused portfolio, including an FDA-approved anti-CD19 ADC.
Clinical development in hematologic cancers and solid tumors
Seeks to expand ZYNLONTA® into earlier lines of diffuse large B-cell and indolent lymphomas and aims to address unmet medical needs in hematologic cancers and solid tumors.
What they work on
- Modalities
- Antibody, ADC, Cell therapy
- Therapeutic areas
- cancer, hematologic cancers, solid tumors, large B-cell lymphoma, diffuse large B-cell lymphoma, indolent lymphomas
- Sites
- Epalinges, Switzerland
- Address
- 430 Mountain Avenue Suite #404 New Providence, NJ 07974, USA
- Founded
- 2020
Similar labs. 3C Therapeutics, AGC Biologics, Bambusa Therapeutics, Intellective Bio
Found in a contract services directory. Listing built from adctherapeutics.com. Work here? Claim this listing.